Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/1999

Inhalt (10 Artikel)

Reversal of estrogen‐resistance in murine mammary adenocarcinomas

María Fernanda Montecchia, Alfredo Molinolo, Claudia Lanari

The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancer

Marzia Becchis, Roberto Frairia, Patrizia Ferrera, Annamaria Fazzari, Sabrina Ondei, Alda Alfarano, Claudio Coluccia, Nicoletta Biglia, Piero Sismondi, Nicoletta Fortunati

Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation

Maurizio Amichetti, Orazio Caffo, Mauro Arcicasa, Mario Roncadin, Ornella Lora, Alberto Rigon, Giampaolo Zini, Luciano Armaroli, Francesca Coghetto, Pierluigi Zorat, Stefanoti Neri, Nazario Teodorani

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

Prema P. Peethambaram, James N. Ingle, Vera J. Suman, Lynn C. Hartmann, Charles L. Loprinzi

Invasion marker PAI‐1 remains a strong prognostic factor after long‐term follow‐up both for primary breast cancer and following first relapse

Nadia Harbeck, Christoph Thomssen, Ursula Berger, Kurt Ulm, Ronald E. Kates, Heinz Höfler, Fritz Jänicke, Henner Graeff, Manfred Schmitt

Tumour necrosis factor‐α and interleukin‐1 and ‐6 in fibrocystic breast disease

Alfonso Herruzo, Jose Antonio Castilla, Angel Ramírez, Cristina Marcos, Salomón Menjón

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

Francesco Di Costanzo, Andrea Sdrobolini, Luigi Manzione, Domenico Bilancia, Luigi Acito, Silvia Gasperoni, Lanfranco Valenti, Lorella Fioriti, Sabrina Angiona, Lucio Giustini

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.